Bovine Colostrum Supplementation in Athletes

计划入组 32 人 · 首次发布于 2023 年 11 月 9 日

Effect of Anti-Inflammatory Agents on Biological Responses to Endotoxin Inhalation in Healthy Subjects

计划入组 51 人 · 首次发布于 2014 年 9 月 30 日

Immunity Modification of Full Term Infants According to the Type of Feeding and Mode of Delivery

计划入组 56 人 · 首次发布于 2020 年 2 月 5 日

BioC (Xinnate)

BINATE

INNATE IMMUNE(Odyssey)

Xinnate AB

Sweden

Innate Pharma

France

Innate Pharma, Inc.

United States

Xinnate Advances TCP-25 for Epidermolysis Bullosa with FDA IND Approval and First Clinical Publication

FDA Grants Orphan Drug Designation to Xinnate's TCP-25 for Epidermolysis Bullosa Treatment

FDA Upgrades Xinnate's TCP-25 Trial for Epidermolysis Bullosa to Registrational Status